Ihe Nchoputa US na European Trial Ekepụtara maka Glucosamine
Na Ụlọ Akwụkwọ American Academy of Rheumatology Annual Scientific Meeting (2005), e si na nyocha abụọ glucosamine pụta. Ihe ndi nchoputa, ndi dibia, na ndi nriaria bu ndi choro ikwenye na glucosamine bu ihe puru ime ihe ozo maka arthritis .
- Gọọmentị National Institute of Health na-akwụ ụgwọ GAIT (Glucosamine / Chondroitin Arthritis Trial) iji mee ka a chọpụta nchebe na nrụpụta ọrụ na glucosamine na chondroitin , wepụtara iche ma ọ bụ ọnụ.
- Onye na-eduzi (Glucosamine Unum na Ọrịa Na-akpata Mgbu) bụ ikpe ikpe na Europe.
GAIT (Glucosamine / Chondroitin Arthritis Intervention Trial) Oge I
Na GAIT (Glucosamine / Chondroitin Arthritis Intervention Trial), ihe fọrọ nke nta ka ọ bụrụ ndị ọrịa 1,600 nwere ọrịa ogbu na nkwonkwo na-egbu mgbu bụ ndị e si na 16 ụlọ akwụkwọ mmụmụ nke United States maka ọmụmụ ihe ahụ. Ndị na-amụ ihe ahụ enweela nnukwu ihe mgbochi ikpere ma nwee ihe ngosi x-ray nke osteoarthritia ikpere. N'oge ọmụmụ GAIT, ndị ọrịa:
- A tụlere ya na mmalite nke ọmụmụ ihe ahụ.
- Elere ya na izu 4, 8, 16, 24.
- Ndị na-arịa ọrịa na-enweghị ohere ịchọta HCl glucosamine, sodium chondroitin sulfate, mmeju abụọ, celecoxib (aha Celebrex) , ma ọ bụ placebo.
- A na-enye ndị ọrịa ruo mg 4 mg kwa ụbọchị nke acetaminophen.
Ihe si na GAIT (Glucosamine / Chondroitin Arthritis Intervention Trial)
- Nsonaazụ gosiri na nchịkọta glucosamine na chondroitin dị mma karịa placebo ma uru dị ka ịdabere na oke mgbu.
- Na ndị ọrịa nwere ihe mgbochi ikpere ikpere na-egbuke egbuke, 79.2% na-ewere glucosamine / chondroitin jikọtara ihe enyemaka mgbu.
- Maka ndị ọrịa na-ewere celecoxib, 69.4% enwere mgbu mgbu. N'ime ndị ọrịa na-ewere glucosamine naanị, 65,7% nwere ahụmahụ, dị ka 61.4% nke ndị ọrịa na-ewere chondroitin naanị. Ọzọkwa, 54.3% na-ewere placebo kọrọ enyemaka mgbu.
- Na ndị ọrịa na-egbu mgbu nke osteoarthritis, glucosamine / chondroitin Nchikota abughi ihe dị irè karịa placebo.
Ntuziaka (Glucosamine Unum na Ọrịa Mgbu)
E nwere mmadụ 318 nọ na ọmụmụ GUIDE na ikpere osteoarthritis (88% inyom). A na-eme ka ndị ọrịa ghara ikwe ka glucosamine sulfate soluble ntụ ntụ (1500 mg otu ugboro n'ụbọchị), acetaminophen (1000 mg ugboro atọ n'ụbọchị), ma ọ bụ placebo karịrị ọnwa isii. A na-ekwe ka ìgwè niile kwere ibuprofen dị ka ọ dị mkpa.
Nsonaazụ sitere na GUIDE (Glucosamine Unum In Diseffice)
- Ma glucosamine sulfate na acetaminophen dị irè n'ịbelata ihe mgbu karịa placebo.
- Ndị ọrịa na-eji glucosamine sulfate gosipụtara enyemaka karịa ndị ọrịa na acetaminophen.
- A kwubiri na otu ugboro kwa ụbọchị kwa ụbọchị, ọgwụgwọ glucosamine sulfate kwa ụbọchị nwere ike ịbụ ọgwụgwọ kachasị mma maka ikpere osteoarthritis.
Oge nke II na oge nke III GAIT Results
E bipụtara nsonaazụ sitere na usoro nke abụọ nke ọmụmụ GAIT n'akwụkwọ akụkọ Arthritis & Rheumatism na 2008. Phase II nyochare nchịkọta nke glucosamine na chondroitin maka igbochi mmebi nkwonkwo ikpere. Nchikota glucosamine na chondroitin enwegh i ihe bara uru n'igbochi mmekorita ndi ozo na osteoarthritis karia placebo.
Ndị na-amụrụ ihe ndị na-atụghị anya na ha nwere ohere karịrị oge abụọ nọ n'etiti ìgwè ndị were glucosamine ma ọ bụ chondroitin naanị. Eleghị anya, iweghachị abụọ ahụ na-emetụta absorption, nke nwere ike ịkọwa njirimara nke ntinye mgbe ejiri ya mee ihe.
Oge nke III, bụ nke a tụlere ngụkọta nke afọ anọ nke data, gosiri na ihe mgbakwunye na njikọta ma ọ bụ naanị enweghi uru dị ukwuu maka mgbu mgbu nke ikpere karịa celecoxib ma ọ bụ placebo. E bipụtara ihe ndị a na 2010 n'akwụkwọ akụkọ Annals of Rheumatic Disease .
Nkwenye maka Glucosamine
- Tupu ị na - agbalị glucosamine / chondroitin kwurịta ya na dọkịta gị ma jụọ ya otú ọ ga - esi kwekọọ na usoro ọgwụgwọ gị ugbu a.
- Gaa na ọgwụ gị. Ihe mgbakwunye abụghị ihe edozi maka ọgwụ gị.
- Mụta banyere glucosamine site n'ime nnyocha nke gị. Chọta isi ihe ọmụma nke a pụrụ ịdabere na ya.
- Soro ntuziaka nke onye na-emepụta emeputa kwuru ma ọ bụ jụọ dọkịta gị banyere usoro kwesịrị ekwesị.
- Zere ijikọta ihe mgbakwunye ndị ọzọ dị iche iche.
- Ịzụta n'aka onye na-ewu ewu. Mara ihe ị na-enweta.
Ndabere ala
N'afọ 2012, Ụlọ Ọrụ American Academy of Rheumatology bipụtara ọgwụgwọ ọgwụgwọ maka ọrịa ogbu na nkwonkwo. Na nduzi, chondroitin ma ọ bụ glucosamine adịghị atụ aro maka ọgwụgwọ mbụ nke ọrịa ogbu na nkwonkwo. Nhọrọ nke chondroitin na glucosamine nanị ma ọ bụ na nchikota nwere ike ọ gaghị abụ ọgwụgwọ dị irè maka ndị ọrịa niile. Ọ nwere ike ịrụ ọrụ maka ụfọdụ ndị ọrịa, ma ọ bụrụ na ọ na-arụ ọrụ maka gị, nọgide na - agwọta ya.
Isi mmalite:
Mmetụta nke glucosamine na / ma ọ bụ cholestroitin sulfate na-arịwanye elu nke ikpere osteoarthritis: akụkọ sitere na glucosamine / chondroitin arthritis na-anwale ikpe. Sawitzke et al. Arthritis & Rheumatism. 2008 Ọkt; 58 (10): 3183-91.
http://www.ncbi.nlm.nih.gov/pubmed/18821708
Glucosamine / Chondroitin Arthritis Intervention Trial (GAIT). NIH. Gbanwee na Jenụwarị 2012.
https://nccih.nih.gov/research/results/gait
Nrụpụta ahụ na nchekwa nke glucosamine, chondroitin sulphate, nchikota ha, celecoxib ma ọ bụ placebo ka a na-agwọ ọrịa ogbugbu nke ikpere: afọ 2 sitere na GAIT. June 2010. Ọkọlọtọ nke Ọrịa Rheumatic. 2010; 69: 1459-1464
Akwukwo Igbo:
Ntuziaka maka iji ọgwụ ndị na-adịghị agwọ ọrịa na ọgwụ na-agwọ ọrịa na Osteoarthritis nke Aka, Hip, na Knee.American College of Rheumatology 2012. (Ọgwụgwọ Arthritis Care & Research Vol. 64, No. 4, April 2012, pp 465-474.)